KimberlyClark (KMB)
(Delayed Data from NYSE)
$142.41 USD
+0.13 (0.09%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $142.44 +0.03 (0.02%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$142.41 USD
+0.13 (0.09%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $142.44 +0.03 (0.02%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth B Momentum B VGM
Zacks News
Will Kimberly-Clark's (KMB) Savings Efforts Pare Cost Woes?
by Zacks Equity Research
Kimberly-Clark (KMB) focuses on enhancing savings through the FORCE and Global Restructuring Programs. However, high input costs are a worry.
Kimberly-Clark (KMB) Up 9% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Kimberly-Clark (KMB) reported earnings 30 days ago. What's next for the company? We take a look at earnings estimates for some clues.
Kimberly-Clark (KMB) Banks on FORCE Program to Offset Costs
by Zacks Equity Research
Kimberly-Clark's robust cost-saving efforts and regular innovation help the company outperform the industry over the past three months.
Kimberly-Clark (KMB) Surges: Stock Moves 5.4% Higher
by Zacks Equity Research
Kimberly-Clark (KMB) was a big mover last session, as the company saw its shares rise more than 5% on the day amid huge volumes.
Kimberly-Clark (KMB) Tops Q2 Earnings, Cuts View on Cost Woes
by Zacks Equity Research
Kimberly-Clark's (KMB) Q2 earnings and sales grow year over year. However, 2018 results are likely to be hurt by considerable commodity inflation.
Kimberly-Clark (KMB) Beats Q2 Earnings Estimates
by Zacks Equity Research
Kimberly-Clark (KMB) delivered earnings and revenue surprises of 1.27% and -0.03%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Kimberly-Clark (KMB) Stock Down Despite Q2 Earnings Beat
by Zacks Equity Research
Kimberly-Clark's (KMB) Q2 earnings came ahead of the Zacks Consensus Estimate and also improved year-on-year.
Can Savings Keep Kimberly-Clark (KMB) Afloat in Q2 Earnings?
by Zacks Equity Research
Kimberly-Clark (KMB) struggles with higher commodity costs and lower selling prices. However, robust cost reduction efforts are likely to aid performance in Q2.
Will Restructuring Plans Revive Kimberly-Clark's Stock?
by Zacks Equity Research
Kimberly-Clark's (KMB) strong focus on its Focus on Reducing Costs Everywhere program as along with its 2018 Global Restructuring plan should help it offset input cost inflation.
The Zacks Analyst Blog Highlights: CSX, Eni, Kimberly-Clark, Caterpillar and Check Point Software
by Zacks Equity Research
The Zacks Analyst Blog Highlights: CSX, Eni, Kimberly-Clark, Caterpillar and Check Point Software
Top Research Reports for CSX Corporation, Eni & Kimberly-Clark
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including CSX Corporation (CSX), Eni (E) and Kimberly-Clark (KMB).
The Zacks Analyst Blog Highlights: Merck, Occidental Petroleum, Capital One Financial, Kimberly-Clark and Allstate
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Merck, Occidental Petroleum, Capital One Financial, Kimberly-Clark and Allstate
Top Analyst Reports for Merck, Occidental Petroleum & Capital One Financial
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Merck (MRK), Occidental Petroleum (OXY) and Capital One Financial (COF).
Why Is Kimberly-Clark (KMB) Up 6.3% Since Its Last Earnings Report?
by Zacks Equity Research
Kimberly-Clark (KMB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Kellogg (K) Discontinues Operations in Crisis-Hit Venezuela
by Zacks Equity Research
Kellogg (K) pulls out of Venezuela citing economic and political disruptions.
Kimberly-Clark Down 9% in 3 Months: Rising Costs the Culprit?
by Zacks Equity Research
Kimberly-Clark (KMB) struggles with higher commodity costs, lower net selling prices and dismal diaper unit performance.
Zacks Industry Outlook Highlights: Amazon, Sysco, Colgate, Campbell Soup and Kimberly-Clark
by Zacks Equity Research
Zacks Industry Outlook Highlights: Amazon, Sysco, Colgate, Campbell Soup and Kimberly-Clark
Zacks Industry Outlook Highlights: Tyson Foods, Newell Brands, Molson Coors, Sysco and Kimberly Clark
by Zacks Equity Research
Zacks Industry Outlook Highlights: Tyson Foods, Newell Brands, Molson Coors, Sysco and Kimberly Clark
Kimberly-Clark (KMB) Posts In-Line Q1 Earnings, Sales Beat
by Zacks Equity Research
Kimberly-Clark's (KMB) first-quarter 2018 results gain from top-line growth across all segments. The company's savings initiative bore positive results.
Kimberly-Clark (KMB) Q1 Earnings & Sales Up Y/Y,Stock Gains
by Zacks Equity Research
Kimberly-Clark (KMB) expects adjusted earnings for 2018 in a range of $6.90-$7.20 per share, reflecting year-over-year growth of 11-16%.
Should Investors Avoid Procter & Gamble (PG) Ahead of Earnings?
by Benjamin Rains
Shares of Procter & Gamble (PG) are down roughly 13% over the last year as the consumer packaged goods giant faces tougher competition from rivals and upstarts. With that said, earnings season could give Procter & Gamble a much needed shot in the arm, if it impresses investors.
Cost-Cutting Plans to Fuel Kimberly-Clark (KMB) Q1 Earnings
by Zacks Equity Research
We remain encouraged about Kimberly-Clark's (KMB) upcoming performance, given its solid FORCE program and recently announced 2018 Global Restructuring plan.
Top Ranked Income Stocks to Buy for April 12nd
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, April 12nd:
These Cosmetic Stocks Scale Fresh Highs: More Room to Run?
by Zacks Equity Research
Constant innovations, product launches and effective initiatives have been favoring Estee Lauder (EL) and Nu Skin. These stocks hit 52-week high yesterday.
Bed Bath & Beyond (BBBY) Q4 Earnings: Is a Beat Likely?
by Zacks Equity Research
Bed Bath & Beyond (BBBY) is on track with its transformation plan, targeting to deliver seamless customer experience. However, soft margin and comps trends remain near-term concerns for the stock.